Will Cannabis Seeds Be Restricted?

A redefinition of hemp under national law, scheduled to take place Nov. 12, signals the loss of Farm Bill safeguards for many hemp-derived THC items across the country: low-dose beverages as well as THCA flower and delta-8 THC gummies, vapes and additional products available at gas stations and smoke shops.

But the hemp prohibition also generates a major complication for the legitimate cannabis industry. Seeds from cannabis cultivars that produce flower with greater than 0.3% THC are no longer legal to ship out of state.

Although seed buying will likely continue in authorized states, the changes threaten to close some seed suppliers and genetics companies, observers say, while causing supply-chain problems for cannabis cultivators and retailers.

"If this wording goes forward, we will require pop-up stores to sell seeds in every state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue cultivation, because that's not covered in the bill."

When are cannabis genetics and clones prohibited to ship across state lines?

The new regulations classify seeds based on the THC potential of the mother plant. Genetic material such as seeds and clones are made illegal if the end product exceeds the threshold.

For now, seeds are currently shipping under the 2018 Farm Bill's status quo. But the time is ticking for businesses like Brothers Grimm and for cannabis cultivators who fear supply chain interruptions if out-of-state availability to genetics is prohibited.

Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without government intervention in the way of a carve-out for seeds or an overall moratorium, numerous seed suppliers will just be shuttered by November, he added.

"We are functioning legally now, but if that shifts, it will upend the legal licensed industry in every state," said Power, whose customers includes seed banks as well as licensed business cultivators.

"Consumers are going to forfeit choice, and it will be a significant shutdown for many people."

What are cannabis seed suppliers doing to stay legal after the federal hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which strengthened cannabis supervision in that state while also limiting hemp-derived THC items to licensed cannabis retailers.

Previously a seed supplier, Silberhaze is currently focused on the branding, preservation and IP safeguarding of premium plant genetics.

That's because seed companies hoping to stay compliant in this updated environment must have solid documentation, he said.

"You have to demonstrate where this stuff comes from, so it's very important to have documentation, even to the extent where you have breeder names," Silber said.

"Small businesses will have to work with improved records and a better chain of possession," he added. "We need that documentation too, because we don't want to be dealing with questionable sources."

To prevent seizures and other legal fallout, https://nativesusa.com/; nativesusa.com, seed business owners must "get their ducks in a row" before the new regulations take effect, Silber said.

"Audit all your stuff immediately, and categorize what you can," Silber said. "Take inventory, document your heritage, preserve breeder records, and arrange any cannabinoid or terpene data you currently have. If regulations change, you'll be in a much better position to understand what may be impacted and make informed decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be necessary for companies engaged in research.

But for the time being, seed houses can't register with the DEA like state-licensed medical cannabis businesses can. Such a pathway is unavailable to seed banks, nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis practice group in Cleveland.

"Seed-related activity may be happening inside broader state-licensed therapeutic marijuana operations, as some states allow dispensaries or registered medical operators to offer seeds, clones or home-cultivation materials," he said.

"But that is distinct from the DEA establishing a freestanding seed supplier registration category."

Some genetics operators are already changing operational practices to comply with the updated law. According to Ickes, they must answer questions including:

• Which of our varieties produce plants over 0.3% total THC?
• Which seeds survive as hemp after Nov. 12, 2026, and which don't?
• What does our inventory look like once we sort it against the viable-seed exclusion?

Ickes also recognizes confusion from clients who believed federal rescheduling of therapeutic marijuana would clarify their situation with financial institutions. However, the latest regulatory wording has shifted those conversations beyond the basics of classification, he said.

"Banks ask whether this particular revenue stream is legal, whether it ties to state-licensed activity, or whether there's cross-state risk," said Ickes.

"After November, a seed supplier selling high-THC genetics can't address the initial question with the hemp classification. It has to point to a legal state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed keep the simpler story."

What's the future of cannabis genetics?

Campanella is a member of a emerging coalition of other breeders, growers and researchers that's saying seeds are more appropriately defined as farm inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement work elsewhere.

"How do you control something based on what it could become one day?" said Campanella. "Our choice is to have that wording removed, or have seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is reorganizing Brothers Grimm to operate outside the reach of changing federal oversight. The business plans to keep its Colorado seed operation while positioning its Oklahoma tissue cultivation facility as a hedge against federal prohibition of cannabis seeds.

As she noted: "If things evolve in a way where we can't concentrate on interstate transport, we'll have other resources to satisfy people's needs without getting ourselves in trouble."